The Centers for Disease Control (CDC) have just recently upgraded their 2017 Recommendations on the Use of Chlorhexidine–Impregnated Dressings for Prevention of Intravascular Catheter–Related Infections
1. For patients aged 18 years and older:
a. Chlorhexidine–impregnated dressings with an FDA–cleared label that specifies a clinical indication for reducing catheter–related bloodstream infection (CRBSI) or catheter–associated blood stream infection (CABSI) are recommended to protect the insertion site of short–term, non–tunneled central venous catheters.
(See Section 5.0 – Implementation Considerations for Patients Aged 18 Years and Older)
a. Chlorhexidine–impregnated dressings are NOT recommended to protect the site of short–term, non–tunneled central venous catheters for premature neonates due to risk of serious adverse skin reactions.
b. No recommendation can be made about the use of chlorhexidine–impregnated dressings to protect the site of short–term, non–tunneled central venous catheters for pediatric patients less than 18 years old and non–premature neonates due to the lack of sufficient evidence from published, high–quality studies about efficacy and safety in this age group.
These recommendations supersede only the two statements about C-I dressings in the section on Catheter Site Dressing Regimens (Recommendations 12 and 13) in the 2011 Guidelines.
The updated recommendations on use of C-I dressings for short-term, non-tunneled CVCs do not supersede other recommendations about tunneled CVCs , peripheral intravenous catheters, arterial catheters, and other topics covered in the 2011 Guidelines.
You can download this updated document directly from the CDC website or clicking this link below;